view the latest feinstein institute for medical research annual report
TRANSCRIPT
-
KEVIN J. TRACEY, MDHead of the Center for Biomedical Science
As a neurosurgery resident, Dr. Tracey met an 11-month-old named Janice who arrived in an ambulance with burns covering 75 percent of her body. She was accidently burned by her grandmother who was cooking, tripped and doused Janice with a pot of boiling spaghetti. Janice spent three weeks recovering in the burn unit and eventually stabilized. At the time, Dr. Tracey played with Janice, who was happy, smiling and giggling. The next day, her medical team was shocked to find her dead. There was no medical explanation for her death, Dr. Tracey was haunted by her case and focused his career path toward researching inflammation, which he believed caused Janices unexpected death.
CENTER FOR BIOMEDICAL SCIENCE
Researchers in the Center for
Biomedical Science discovered
that the brain controls the
immune systemmore
specifically, a nerve in the neck
signals the release of natural
chemicals the body needs to treat
disease. The center is pioneering
a new field of medicine called
bioelectronic medicine, which
uses small devices to tell the
body to treat itself without
manufactured drugs or their side
eff ects. Bioelectronic medicine
has the potential to treat a wide-
ranging number of diseases,
including arthritis, lupus, obesity,
type 2 diabetes, inflammatory
bowel disease and even
certain cancers.
Dr. Tracey, center, in the lab.
9
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
NICHOLAS CHIORAZZI, MDHead of the Center for Chronic Lymphocytic Leukemia
Dr. Chiorazzi trained at North Shore University Hospital and returned 13 years later as a scientist. It was at this time that he made discoveries in CLL B cells, which compelled Dr. Chiorazzi to turn his focus exclusively to CLL. He and his colleagues in the center have investigated the control of CLL B cell activation, and their findings have significantly impacted the understanding of leukemia cells in patients with CLL. Dr. Chiorazzi continues to conduct research in the hopes of curing the disease.
CENTER FOR CHRONIC LYMPHOCYTIC LEUKEMIA
Those in the Center for Chronic
Lymphocytic Leukemia study
the activation and maturation
of B-lymphocytes, and use this
information to develop and test
new diagnostics and treatments
for patients suff ering from chronic
lymphocytic leukemia (CLL).
CLL is a B-lymphocyte cancer
that resides in the blood, bone
marrow and lymphoid tissues.
It is the most common type of
leukemia in adults. It is called
chronic because it progresses
more slowly than other types
of leukemia.
Dr. Chiorazzi, second from left , in the lab
10
2015 ANNUAL REPORT
-
PETER K. GREGERSEN, MDHead of the Center for Genomics & Human Genetics
When Dr. Gregersen was a medical resident in the late 1970s, a young woman with lupus died under his care and he realized at that moment there was a need to generate knowledge about autoimmune diseases. He then began a rheumatology fellowship at a time when modern molecular biology and genetics were exploding, and he successfully cloned the first HLA genes for rheumatoid arthritis. This convinced him that research was the most important and exciting thing he could do with his life. Today, Dr. Gregersen pursues genetics research with a highly collaborative style, providing him with extraordinary connections and friendships around the world.
CENTER FOR GENOMICS & HUMAN GENETICS
The mission of the Center for
Genomics & Human Genetics
is to identify and understand
the genetic contribution to
human diseases and translate
these discoveries into new
diagnostics and therapeutics.
Center researchers are focused
on autoimmune diseases and
neuropsychiatric traits and
disorders, and conduct a full
range of human genetics research.
11
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
EDMUND J. MILLER, PHDHead of the Center for Heart & Lung Research
Dr. Miller started his scientific career in a pathology department, analyzing samples from patients to try to diagnose a disease state. He later joined a research group that studied acute lung injury. He was intrigued and fulfilled by this work and continues to study acute lung injury as well as chronic lung dysfunction. His current interest is in developing a better understanding of the mechanisms involved when the lung does not function properly and the consequences for both the lungs and the rest of the body. To him, the exciting part of research is the development of new ways to treat individuals with lung disease.
CENTER FOR HEART & LUNG RESEARCH
The Center for Heart & Lung
Research brings together
basic and clinical scientists
who have an interest in the
cardiopulmonary system. A major
focus of the Center is the study
of pulmonary hypertension, a
condition that can occur at any
age. Blood vessels in the lungs
narrow, causing poor blood flow
through the lungs. This results in
low oxygen in the blood, pressure
in the lungs and a strain on the
heart, which eventually causes
the heart to fail. The center
studies the cardiopulmonary
mechanisms that are
dysfunctional and their eff ects on
other organs, including the brain.
The goal of this research is to
prevent or correct the dysfunction
to improve quality of life and
prevent death.
Dr. Miller, on the left , in the lab
12
2015 ANNUAL REPORT
-
BARBARA SHERRY, PHDHead of the Center for Immunology & Inflammation
Growing up on Long Island, Dr. Sherry never knew a scientist, but she was always interested in science and it was her dream to work in a laboratory. In middle school, she spent a year working on her own research project that won her the schools top award and gave her the opportunity to describe her research findings to her teachers and fellow students. She loved sharing what she discovered with others. From that moment, she was determined to pursue a career in research.
CENTER FOR IMMUNOLOGY & INFLAMMATION
Researchers in the Center for
Immunology & Inflammation
focus on understanding the basic
biological principles of the immune
system that protects the body
against infections, environmental
hazards and internal challenges,
and how this system is impaired
in disease. They carry out basic,
translational, and patient-oriented
research on a range of immune and
inflammatory disorders, including
sepsis, allergy and hypersensitivity,
kidney injury, cancer, immune
deficiency, HIV infection and
conditions aff ecting maternal, fetal
and neonatal health. Their ultimate
goal is to develop improved
treatments and discover cures for
these life-threatening conditions.
13
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
YOUSEF AL-ABED, PHDHead of the Center for Molecular Innovation
Like most 14-year-olds, Dr. Al-Abed liked to play with his neighborhood friends. One day, he witnessed something that he could not comprehend; his best friend had his first seizure. No one knew what to do. For Dr. Al-Abed, those minutes were the longest of his life. Later, Dr. Al-Abed learned that his friend was diagnosed with epilepsy. He was shocked by how suddenly his friend changed from being just like him to being aff licted with illness. He was consumed with the question of how one day people can be normal and then the next day completely changed. This question compelled Dr. Al-Abed to pursue chemistry, science and medicine, inspiring his work to discover new therapies to help patients.
CENTER FOR MOLECULAR INNOVATION
The Center for Molecular
Innovation leads the discovery
and development of novel
therapeutics for human diseases,
including lupus, arthritis,
diabetes, Alzheimers disease and
sepsis. It integrates approaches
in target discovery with medicinal
chemistry to generate small
organic compounds and potential
drugs. The center has successfully
identified several drug candidates
and has repurposed existing
drugs to target critical proteins
involved in neurodegenerative
and autoimmune diseases.
Dr. Al-Abed, center, in the lab
14
2015 ANNUAL REPORT
-
DAVID EIDELBERG, MDHead of the Center for Neuroscience
Dr. Eidelbergs post-doctoral training led to a position in a research lab working with PET imaging. He brought PET research to North Shore University Hospital two decades ago. Since that time, he has developed novel imaging techniques that aid in diagnosing and evaluating the progression of Parkinsons disease. His state-of-the-art PET imaging methods are also used to further understand how current therapies treat Parkinsons disease.
CENTER FOR NEUROSCIENCE
The mission of the Center for
Neuroscience is to shed light on
the abnormalities of functional
brain organization that underlie
nervous system disease. To
characterize these networks
as biomarkers of disease and
treatment, investigators use
multimodal brain imaging
in conjunction with novel
computational methods. Study
populations include healthy
volunteers and patients with
Parkinsons disease, Alzheimers
disease, Huntingtons disease,
dystonia and Tourette syndrome.
15
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
THOMAS L. ROTHSTEIN, MD, PHDHead of the Center for Oncology & Cell Biology
One Saturday morning, at age 12, Dr. Rothstein awoke with severe abdominal pain. Aft er an off ice examination, he overheard the doctor telling his parents you know, people still die from ruptured appendices. As he recovered from surgery, those words rang in Dr. Rothsteins ears. It was then that he decided to become a doctor so that he could help others. A year later, Dr. Rothstein had his first science class in 7th grade. He was, for the first time, exposed to the world of scientific thinking and was totally captivated. These two experiences put Dr. Rothstein on the track he continues to pursue today being an MD/PhD physician-scientist, who advances science to improve patients lives.
CENTER FOR ONCOLOGY & CELL BIOLOGY
Researchers in the Center for
Oncology & Cell Biology study
cancer and related aspects of
cell biology, all geared toward
understanding the abnormal
growth and behavior of cells
that have been malignantly
transformed. These eff orts
include finding ways to harness
the bodys own immune system
to attack cancerous growths
through antibodies and T cells,
approaches that are currently in
clinical trials.
Dr. Rothstein, center, in the lab
16
2015 ANNUAL REPORT
-
JEFFREY M. LIPTON, MD, PHDHead of the Center for Patient-Oriented Research
As a grade school student, aft er seeing the Soviet Union launch Sputnik in 1957, Dr. Lipton knew he wanted to be a scientist. But, his fear of heights and poor sense of direction steered him away from aerospace and toward the lab. He obtained his MD and PhD and his long-standing interest in the biology of blood cell production led him to focus on Diamond-Blackfan anemia.
CENTER FOR PATIENT-ORIENTED RESEARCH
The major goal for investigators
in the Center for Patient-Oriented
Research is patient-directed
research. This includes clinical
trials, epidemiology and
statistics and focused laboratory
science. For example, a team of
researchers in the center focuses
on the elucidation of the genetics
and pathophysiology of Diamond-
Blackfan anemia (DBA), a rare
bone marrow disorder. They work
to translate laboratory knowledge
into relevant diagnostic and
therapeutic tools.
Dr. Lipton, on the right, in the lab
17
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
JOHN M. KANE, MDHead of the Center for Psychiatric Neuroscience
Dr. Kane has been fascinated by behavior and emotion since he was a child. In medical school, he encountered a patient who suff ered from schizophrenia and bizarre delusions. Dr. Kane was intrigued by these dramatic and disabling symptoms, and was even more interested in how medicines available at the time reduced patients symptoms. Since that day, Dr. Kane has been dedicated to researching drug discovery and the development of new treatments for schizophrenia.
CENTER FOR PSYCHIATRIC NEUROSCIENCE
The mission of the Center for
Psychiatric Neuroscience is to
study behavioral health to identify
causes, triggers, markers and
treatments for such illnesses as
bipolar disorder, schizophrenia
and other psychotic disorders.
Combining diff erent perspectives
in multi-disciplinary research is
key to making advances in these
illnesses. The Feinstein Institute
and the Zucker Hillside Hospital
provide valuable platforms to
advance such eff orts.
18
2015 ANNUAL REPORT
-
PING WANG, MDHead of the Center for Translational Research
Dr. Wang grew up in an industrial city where there was much emphasis on machinery. Being born and raised in this environment, it was natural for him to have a deep interest in figuring out how and why machines worked the way they did. When medicine was introduced to him later in life, he applied his interest in machinery and grew a curiosity to discover how the human body works and what causes disease. Today, Dr. Wang believes that parts of the human body work together to form a beautiful machine that is far more complicated than anything humans have created or even imagined. He works toward the goal of conducting eff ective and successful laboratory discoveries and translating them into clinical practice for improving patient outcome.
THE CENTER FOR TRANSLATIONAL RESEARCH
The Center for Translational
Research promotes the
identification of therapeutic
targets, the development
of treatment strategies,
and the validation of
preclinical studies, leading to
commercialized technologies
for diagnosing or treating
human disease. Through
cohesive collaboration,
researchers in the center work
together and share ideas in
hope of advancing biomedical
technologies in various
research fields.
19
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
There are 800 Feinstein Institute investigators and staff who conduct research in immunology, inflammation, neurology, obstetrics/gynecology, oncology, pediatrics, psychiatry, surgery, urology, genetics and many other specialties. These scientists collaborate with nearly 10,000 physicians across the North Shore-LIJ Health System. Together, they touch the lives of millions of patients each year in the health systems 19 hospitals, more than 400 outpatient physician practices and a vast network of skilled-nursing home care rehabilitation facilities. The health systems 2,200-square-mile footprint throughout the New York metropolitan area includes some of the most ethnically-diverse communities in the US, providing an immense opportunity for clinical research faculty and staff who recruit more than 15,000 subjects per year into more than 2,100 studies.
Feinstein Institute investigators are internationally-acclaimed authorities in their scientific and medical fields. They win prestigious awards, belong to exclusive scientific and medical honor societies, and are invited worldwide to lecture about their research. Their discoveries are published in the most prestigious scientific and medical journals.
The directory to follow highlights select Feinstein Institute investigators organized first by their specialty and then alphabetically by name.
* this directory includes researchers who have a Feinstein Institute appointment, are Investigators and/or are on a scientific track.
RESEARCH DIRECTORY
20
2015 ANNUAL REPORT
-
RESEARCH DIRECTORY
Autoimmune Research
AUTOIMMUNE & MUSCULOSKELETAL DISEASECynthia Aranow, MD Ona E. Bloom, PhDNadeen Chahine, PhD Anne Davidson, MBBSBetty Diamond, MDGiovanni Franchin, MD, PhD Richard A. Furie, MDPatricio Huerta, PhD Sun Jung Kim, PhDCzeslawa Kowal, PhDMeggan Mackay, MD Frances Santiago-Schwarz, PhDMyoungsun Son, PhDAndrea Vambutas, MDYong-Rui Zou, PhD
BIOMEDICAL SCIENCESangeeta S. Chavan, PhDCliff Deuschman, MDJared Huston, MD Valentin A. Pavlov, PhDJesse Roth, MDKevin J. Tracey, MDBruce T. Volpe, MD Haichao Wang, PhD Huan Yang, MD, PhD
IMMUNOLOGY & INFLAMMATIONVincent R. Bonagura, MDSleiman Ghorayeb, PhDChristine Metz, PhDRichard J. Schanler, MDBarbara Sherry, PhDPravin C. Singhal, MD
Brain Research
ALZHEIMERS DISEASE & MEMORY DISORDERSPeter Davies, PhDConcepcion Goldberg, MD, PhDMarc L. Gordon, MDPhilippe Marambaud, PhD
NEUROSCIENCEJohn Boockvar, MDStephen L. Dewey, PhDVijay Dhawan, PhDDavid Eidelberg, MD Deborah Elkis-Abuhoff, PhDAndrew S. Feigin, MDChunyan Li, PhDAshesh Mehta, MD, PhD Michael Schulder, MDAziz M. Ulug, PhD
PSYCHIATRIC NEUROSCIENCEBarbara A. Cornblatt, PhDChristoph U. Correll, MD Juan A. Gallego, MDTerry Goldberg, PhD Vivian Kafantaris, MDJohn M. Kane, MDKatherine Karlsgodt, PhDJeremy Koppel, MDTodd Lencz, PhDAnil Malhotra, MDDelbert G. Robinson, MD Keith M. Shafritz, PhDPhilip R. Szeszko, PhDJianping Zhang, MD, PhD
Cancer Research
CHRONIC LYMPHOCYTIC LEUKEMIA Nicholas Chiorazzi, MD Charles C. Chu, PhD Patricia K.A. Mongini, PhD Kanti R. Rai, MD
ONCOLOGY & CELL BIOLOGYLionel Blanc, PHD Daniel R. Budman, MDDaniel A. Grande, PhDBenchang Guo, PhDJohnson Liu, MDLouis Potters, MD Thomas L. Rothstein, MD, PhDRosamaria Ruggieri, PhDSharon Singh, MDSamuel Z. Soffer, MDBettie M. Steinberg, PhDMarc H. Symons, PhDSarah Vaiselbuh, MD
Genomics & Human GeneticsPeter K. Gregersen, MDAnnette T. Lee, PhD
Heart & Lung ResearchHarly Greenberg, MD Shu Fang Liu, MD, PhD Edmund Miller, PhD Kaie Ojamaa, PhD Saul R. Powell, PhD Arunabh Talwar, MD
Molecular InnovationYousef Al-Abed, PhD
Patient-Oriented ResearchLouis R. Kavoussi, MDMartin L. Lesser, PhDJeffrey M. Lipton, MD, PhDThomas McGinn, MDJacqueline Moline, MD Raj K. Narayan, MDRenee Pekmezaris, PhDCharles Schleien, MD Robert A. Silverman, MDHenry Simpkins, MD, PhDAdrianna Vlachos, MD
Translational ResearchMax Brenner, MD, PhDHoracio Rilo, MDPing Wang, MD
21
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
RESEARCH DIRECTORY
Dr. Al-Abed leads the Center of Molecular Innovation, which aims to discover and develop novel therapeutics for human diseases including lupus, arthritis, diabetes, Alzheimers disease and sepsis. This research integrates target discovery with medicinal chemistry to generate small organic compounds and potential drugs.
Recurrent respiratory papillomatosis (RRP) is a disease caused by the human papillomavirus (HPV)it is the recurrence of tumors of the upper airway that can lead to airway blockages and suffocation. Dr. Bonagura studies the immune response to HPV to understand why RRP patients do not produce the needed immune response to prevent or control the virus.
Dr. Aranow specializes in lupus and rheumatoid arthritis. She is the clinical director of the Feinstein Institute Center for Clinical Research in Autoimmune Disease and co-director of the Clinical Trials Unit. She conducts studies to better understand and develop treatments for diseases such as lupus and rheumatoid arthritis.
Dr. Boockvars research interests focus on malignant brain tumor formation, treatment and ways to overcome resistance to therapy. In addition to his basic science interests, he currently conducts multiple clinical trials using blood-brain barrier disruption to deliver high-dose chemotherapy for patients with malignant brain tumors.
Dr. Blancs research focuses on developmental erythropoiesis and its impairment in pathological conditions and why genetic disorders in erythroid development trigger a cancer predisposition in children, notably osteogenic sarcoma.
Dr. Brenners research goal is to discover and develop better treatments for patients with autoimmune and inflammatory diseases. Recent areas of focus include rheumatoid arthritis and inflammatory bowel disease.
The focus of Dr. Blooms research is to identify the molecular factors necessary to recover from central nervous system (CNS) injury or disease. Towards that goal, her lab is investigating factors that influence the course of CNS injury or disease, as well as the process to recover from CNS injury or disease.
Dr. Budman conducts preclinical, translational and phase I, II and III clinical research in an effort to determine new drug developments for cancer.
YOUSEF AL-ABED, PHDMolecular Innovation
VINCENT R. BONAGURA, MDImmunology & Inflammation
CYNTHIA ARANOW, MD Autoimmune &
Musculoskeletal Disease
JOHN BOOCKVAR, MDNeuroscience
LIONEL BLANC, PHDOncology & Cell Biology
MAX BRENNER, MD, PHDTranslational Research
ONA E. BLOOM, PHDAutoimmune &
Musculoskeletal Disease
DANIEL R. BUDMAN, MDOncology & Cell Biology
22
2015 ANNUAL REPORT
-
RESEARCH DIRECTORY
Dr. Chahines research focuses on degeneration and regeneration of musculoskeletal tissues, particularly intervertebral disc, articular cartilage and tendonous tissues. Her lab uses tools of bioengineering, cellular and molecular biology and animal physiology to develop new treatment strategies for repairing arthritic and diseased musculoskeletal tissues.
The major focus of Dr. Chavans research is in bioelectronic medicine, and developing knowledge about the neuroanatomical pathways and neural codes in the vagus nerve that underlie its regulation of the immune response. She also works to develop targeted therapeutics for the treatment of long-term effects of inflammatory diseases.
Dr. Cornblatts research focus is on the early identification and treatment of adolescents and young adults who are considered to be at-risk for developing serious psychiatric illness as adults, especially schizophrenia and other psychotic disorders. She directs the Recognition and Prevention (RAP) program.
Dr. Chiorazzi studies the activation and maturation of B-lymphocytes, and uses this information to develop and test new diagnostics and treatments for patients suffering from chronic lymphocytic leukemia (CLL), a B-lymphocyte cancer residing in the blood, bone marrow and lymphoid tissues. His studies have impacted CLL patient prognosis and care.
Dr. Correll researches the identification and treatment of patients with severe psychiatric disorders. His areas of focus include schizophrenia-spectrum, mood-spectrum and aggressive-spectrum disorders. He is also an expert in the risk-benefit evaluation of psychotropic medications.
Dr. Chus research interests are currently focused on understanding the molecular basis for the development of B cell chronic lymphocytic leukemia (CLL). More broadly, he is interested in B cell biology, particularly B cell maturation and development and its relationship to disease and autoimmunity.
The current interests of Dr. Davidson are focused on pathogenesis and therapy of lupus. Her labs first goal is to understand more about the regulation of autoantibody-producing B cells and to use newly-discovered pathways of immune activation to design and test novel therapies for lupus.
NADEEN CHAHINE, PHD Autoimmune &
Musculoskeletal Disease
SANGEETA S. CHAVAN, PHD Biomedical Science
BARBARA A. CORNBLATT, PHDPsychiatric Neuroscience
NICHOLAS CHIORAZZI, MDChronic Lymphocytic Leukemia
CHRISTOPH U. CORRELL, MDPsychiatric Neuroscience
CHARLES C. CHU, PHDChronic Lymphocytic Leukemia
ANNE DAVIDSON, MBBSAutoimmune &
Musculoskeletal Disease
The major goal of Dr. Davies research is to improve the understanding of Alzheimers disease to allow for the discovery, development and testing of effective therapies. Recent work focuses on activation of cell cycle mechanisms in Alzheimers disease and modifications of the microtubule associated protein tau as a reporter for signal transduction in the human brain.
PETER DAVIES, PHDAlzheimers Disease &
Memory Disorders
23
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
RESEARCH DIRECTORY
Dr. Feigin directs the Laboratory of Experimental Therapeutics for Movement Disorders, which conducts clinical trials of new therapies for Parkinsons disease, Huntingtons disease and other movement disorders. Dr. Feigin is particularly interested in utilizing PET imaging methods as a biomarker for neurodegenerative disorders in the preclinical phase of illness.
Dr. Dhawans research focuses on how biophysics and bioengineering can be applied to neuroscience, and particularly to the study of disease mechanisms in movement disorders and other neurodegenerative conditions.
Dr. Franchins recent focus is on clinical research and patient care. He is interested in lupus and rheumatoid arthritis, and is involved with clinical trials looking at new therapeutic targets for these diseases. He is also investigating the link between metabolism and disease activity in patients with lupus.
Dr. Diamond studies the induction and pathogenicity of DNA-reactive antibodies in lupus. These studies are designed to provide new strategies to prevent autoimmunity or protect against tissue damage in lupus. She also studies the contribution of maternal antibody to abnormal brain development.
Dr. Deutschman investigates sepsis. Laboratory work includes determinants of organ dysfunction, with emphasis on mitochondrial dysfunction, aberrant signal transduction and abnormalities of neural and endocrine control mechanisms. Clinical projects focus on epidemiologically based definitions of sepsis. He is also involved in both laboratory and clinical investigations throughout the Department of Pediatrics.
Dr. Eidelberg directs an imaging research program in brain disease. His program has developed novel imaging techniques to characterize and quantify neural circuits in neurodegenerative disorders and to study their modulation by using functional imaging with PET and fMRI. This approach has provided unique insights into Parkinsons disease and related movement disorders.
Dr. Dewey studies the effects of substance abuse on brain function and structure. He has researched brain exposure to caffeine, tobacco, alcohol, marijuana, cocaine, methamphetamine, opiates, heroin and chemical solvents, and most recently focused on developing a novel treatment for drug abuse.
Dr. Elkis-Abuhoffs research interests bring together behavioral medicine and creative/medical art therapy with neuroscience. Her recent research projects connect art therapy with those diagnosed with Parkinsons disease, cancer and connecting the creative process to neurological responses.
ANDREW S. FEIGIN, MD Neuroscience
VIJAY DHAWAN, PHDNeuroscience
GIOVANNI FRANCHIN, MD, PHD Autoimmune &
Musculoskeletal Disease
BETTY DIAMOND, MDAutoimmune &
Musculoskeletal Disease
CLIFF DEUTSCHMAN, MDBiomedical Science
DAVID EIDELBERG, MDNeuroscience
STEPHEN L. DEWEY, PHDNeuroscience
DEBORAH ELKIS-ABUHOFF, PHDNeuroscience
24
2015 ANNUAL REPORT
-
RESEARCH DIRECTORY
Dr. Ghorayebs research includes diagnostic and therapeutic ultrasound in orthopaedics, dentistry, ophthalmology, urology and obstetrics and gynecology. Projects include assessment of osteoporosis; dental pulp stem cells; penile, testicular and cervical tissue characterization; retinal reattachment; and evaluation of cartilage implanted with preconditioned scaffolds.
Dr. Goldberg works to examine RNAs found in the brain using microarray technology. She studies abnormal expression of RNA in tissue from people at high risk or currently suffering from Alzheimers disease. She is working to identify novel brain chemicals that can become treatment targets for new drugs.
The goal of Dr. Furies research is to investigate the signaling pathways in myeloproliferative diseasesa group of conditions that cause blood cells to grow abnormally in the bone marrowover the course of the disease. Understanding these mechanisms could allow for the development of more efficacious and better-targeted therapies.
Dr. Goldberg is designing the next generation of neurocognitive assessments for patients with psychiatric disease. These tests will be used to diagnose and follow patients over time to see whether the treatments help in improving symptoms.
Dr. Gallegos current research focus is on the role of microRNAs in cerebrospinal fluid and peripheral blood in patients with schizophrenia. Additionally, he is conducting a study using induced pluripotent stem cells derived from first-episode psychosis patients.
The focus of Dr. Gordons research is in behavioral neurology and neuropsychiatry. He leads clinical research studies in Alzheimers disease, mild cognitive impairment and vascular dementia. His current research involves clinical trials of novel medications, biomarker studies and imaging techniques.
SLEIMAN GHORAYEB, PHDImmunology & Inflammation
CONCEPCION GOLDBERG, MD, PHDAlzheimers Disease &
Memory Disorders
RICHARD A. FURIE, MDAutoimmune &
Musculoskeletal Disease
TERRY GOLDBERG, PHD Psychiatric Neuroscience
JUAN A. GALLEGO, MDPsychiatric Neuroscience
MARC L. GORDON, MDAlzheimers Disease &
Memory Disorders
Dr. Grandes research aims to improve treatments for injuries of the musculoskeletal system, including cartilage regeneration and repair, meniscus repair, tendon repair and bone fracture augmentation and fusion. Recent focus has been on developing novel cell-modified scaffolds for enhancing tendon repair and methods to provide gene therapy and tissue-engineered constructs for bone injuries.
Dr. Greenbergs educational and research efforts are in the field of sleep medicine. Recent work has focused on the cardiovascular pathophysiology of sleep apnea and intermittent hypoxia, assessing functional outcomes of sleep apnea therapy and on developing novel diagnostic and screening modalities for sleep-disordered breathing.
DANIEL A. GRANDE, PHDOncology & Cell Biology
HARLY GREENBERG, MD Heart & Lung Research
25
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
RESEARCH DIRECTORY
Dr. Karlsgodts research investigates the neural circuitry underlying the executive functions, such as working memory, in individuals with severe psychiatric illness. Her work has incorporated methods such as functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI) and studies in relevant patient populations such as schizophrenia and bipolar disorder.
Dr. Huerta is interested in exploring the interactions between the nervous system and the immune system in health and disease. He currently studies brain abnormalities occurring in lupus and sepsis-induced long-term cognitive deficit, with the goal to isolate key immune and neural mechanisms with the purpose of creating therapies for autoimmunity and brain disorders.
Dr. Kavoussi is dedicated to the treatment of urological disease through innovative surgical procedures, diagnostics and medical care.
The focus of Dr. Hustons research is to understand how the central nervous system maintains homeostasis and protects against traumatic injury. He is currently studying the beneficial effects of vagus nerve stimulation with the hope that it can improve care of traumatized patients.
Dr. Gregersen conducts international collaboration efforts to achieve a comprehensive genetic description for autoimmune diseases, with a particular focus on lupus and rheumatoid arthritis. He also studies a number of newly defined risk genes for autoimmunity, several of which are potential targets of new drugs.
Dr. Kafantaris main research focus is the pharmacological treatment of bipolar disorder and the related area of severe dysregulated aggression associated with conduct disorder or oppositional defiant disorder. She currently studies the neurodevelopmental underpinnings of bipolar disorder and treatment with lithium.
Dr. Guo studies antigen-initiated B cell activation under the influence of T cells. He works to find a dialogue between B cells and T cells in immunity.
Dr. Kanes focus is in the field of schizophrenia research. His work has focused on improving the early diagnosis and treatment of schizophrenia, as well as developing new treatments and treatment strategies to enhance patient long-term effectiveness and quality of life.
KATHERINE KARLSGODT, PHD Psychiatric Neuroscience
PATRICIO HUERTA, PHD Autoimmune &
Musculoskeletal Disease
LOUIS R. KAVOUSSI, MD Patient-Oriented Research
JARED HUSTON, MDBiomedical Science
PETER K. GREGERSEN, MDGenomics & Human Genetics
VIVIAN KAFANTARIS, MDPsychiatric Neuroscience
BENCHANG GUO, PHDOncology & Cell Biology
JOHN M. KANE, MDPsychiatric Neuroscience
26
2015 ANNUAL REPORT
-
RESEARCH DIRECTORY
Dr. Kowals research focuses on the mechanisms of the antibody-mediated neuronal abnormalities leading to brain pathology and to hormonal serum alterations in lupus. Projects include the function of the blood-brain barrier in the antibody-mediated pathology of the adult brain and of the maternal antibody-mediated abnormalities in the developing brain.
Dr. Lees current research focus is to discover and validate new biomarkers for early detection, prediction of disease course and outcome and treatment response in cancer, particularly breast and ovarian cancers.
The focus of Dr. Kims research is to identify regulatory mechanisms of inflammatory function of dendritic cells under both homeostatic and inflammatory conditions. This is with the goal to understand the molecular mechanisms that inhibit the development of autoimmune diseases, particularly in lupus and inflammatory bowel diseases.
Dr. Lencz researches the use of biomarkers, especially novel genetic technologies, to better understand the causes and treatment of schizophrenia. He develops and implements strategies for identifying relationships between genetic variation and psychiatric disease, and examines the role that schizophrenia risk genes play in brain structure, function and development.
Dr. Koppels research program focuses on elucidating the biology of behavioral disturbances in Alzheimers disease and the development of novel treatments. Recent work has focused on the endocannabinoid system in Alzheimers disease and the contribution of abnormal tau protein deposition to the development of psychotic symptoms.
Dr. Lesser is a biostatistician and assists investigators in data analysis, research question formulation, study design, data management, storage and retrieval, as well as publication preparation and patient safety and data quality monitoring.
CZESLAWA KOWAL, PHDAutoimmune &
Musculoskeletal Disease
ANNETTE T. LEE, PHDGenomics & Human Genetics
SUN JUNG KIM, PHDAutoimmune &
Musculoskeletal Disease
TODD LENCZ, PHDPsychiatric Neuroscience
JEREMY KOPPEL, MDPsychiatric Neuroscience
MARTIN L. LESSER, PHDPatient-Oriented Research
Dr. Lis research is focused on monitoring and treating the injured brain. Projects include developing the next generation brain multimodality monitoring devices using BioMEMS technology, and investigating trigeminal nerve stimulation as a novel therapeutic approach to traumatic brain injury by the activation of endogenous neuroprotective mechanisms.
The goal of Dr. Liptons research is the elucidation of the genetics and pathophysiology of Diamond-Blackfan anemia (DBA), a disorder of the bone marrow. He is working with numerous collaborators to develop genotype-phenotype correlations, resulting in the discovery of a number of DBA genotypes.
CHUNYAN LI, PHDNeuroscience
JEFFREY M. LIPTON, MD, PHD Patient-Oriented Research
27
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
RESEARCH DIRECTORY
Dr. McGinn has taught, researched and worked in the area of academic general internal medicine with a focus on providing high-quality health care in urban communities. Recent areas of focus include the validation of clinical prediction rules, as well as the prevalence, risk factors and treatment of hepatitis C.
Dr. Mehtas lab uses multiple methods for measuring brain structure and function to advance understanding of human brain function and the treatment of epilepsy. The lab works to improve the diagnosis of epilepsy patients, and better understand the root causes of epilepsy, and the physiological basis of brain structure, function and cognition.
Dr. Mackay is a rheumatologist whose primary interests are in lupus, rheumatoid arthritis, scleroderma and vasculitis. She is a co-director of the Clinical Trials Unit and conducts studies to better understand and develop treatments for autoimmune disease.
Dr. Lius research career has focused on the molecular basis of hematopoietic stem cell disorders, collectively referred to as the inherited bone marrow failure syndromes. His current research is aimed at understanding the molecular pathophysiology of Diamond Blackfan anemia and Shwachman-Diamond syndrome. His lab also researches erythropoiesis and sickle cell anemia.
Dr. Metzs research focuses on inflammation in both pregnant and non-pregnant populations and identifying ways to reduce and prevent dysfunctional inflammation. Much of her work centers on endothelial cells, which facilitate the rapid transport of blood and immune cells throughout the body, particularly to sites of infection and inflammation.
Dr. Malhotra works on identifying the biological underpinnings of schizophrenia and determining how antipsychotic drugs work to quell the symptoms of the disease. His group assesses genes and neural circuits associated with increased risk for schizophrenia with the goal of developing more effective treatments.
Dr. Lius research focus is on molecular mechanisms of septic shock, and septic multiple organ injury. Using modern molecular biology techniques, his goal is to discover the key molecules that can be new targets for developing new therapies.
Dr. Marambauds research focuses on the molecular basis of neuronal degeneration in Alzheimers disease and other dementias. His laboratory studies the early biochemical changes leading to the formation of two classic lesions of the Alzheimers disease brain: the senile plaques and the neurofibrillary tangles.
THOMAS MCGINN, MD Patient-Oriented Research
ASHESH MEHTA, MD, PHD Neuroscience
MEGGAN MACKAY, MD Autoimmune &
Musculoskeletal Disease
JOHNSON LIU, MDOncology & Cell Biology
CHRISTINE METZ, PHDImmunology & Inflammation
ANIL MALHOTRA, MDPsychiatric Neuroscience
SHU FANG LIU, MD, PHDHeart & Lung Research
PHILIPPE MARAMBAUD, PHDAlzheimers Disease &
Memory Disorders
28
2015 ANNUAL REPORT
-
RESEARCH DIRECTORY
Dr. Moline develops initiatives aimed at promoting and engaging health and wellness, and she oversees a population health and epidemiology research program. Her research interests include World Trade Center health effects, asbestos exposure, occupational lung disorders and heavy metal toxicity.
Dr. Monginis research focuses on the immune systems B cells and why B cells sometimes become pathogenic and cause disease. Understanding how to prevent the abnormal development of pathogenic B cells is a critical challenge particularly given the greater emergence of B cell malignancy and certain autoimmune diseases with increased age.
Dr. Narayans research aims to develop the next generation of human monitoring devices, with a particular focus on the monitoring of the injured brain. His recent work has focused on the development of a smart catheter for the monitoring of multiple physiological parameters simultaneously with a single monitor.
Dr. Millers research focuses on lung inflammation and the role of the lung as an inflammatory organ. The studies in his lab involve both acute and chronic disorders that impact the lung. He is closely studying the role of MIF in severe sepsis and pulmonary hypertension.
The goal of Dr. Ojamaas research is to understand the causes of heart disease so that novel therapeutics can be developed. She studies inflammation and neuro-hormones during a heart attack, and why the heart often fails in the long term. In the newborn patient with congenital heart defects, her studies address how increased inflammation may affect neurodevelopment.
JACQUELINE MOLINE, MD Patient-Oriented Research
PATRICIA K.A. MONGINI, PHDChronic Lymphocytic Leukemia
RAJ K. NARAYAN, MDPatient-Oriented Research
EDMUND MILLER, PHD Heart & Lung Research
KAIE OJAMAA, PHD Heart & Lung Research
Dr. Pavlovs research focuses on the regulation of immune function and inflammation by the nervous system. He studies the role of brain and peripheral neuronal pathways in controlling cytokine responses and inflammation, and the therapeutic efficacy of cholinergic modalities in inflammatory and obesity-driven disorders and cancer-associated immune dysfunction.
With an emphasis on the growing population of seniors, Dr. Pekmezaris conducts community-based research investigations with seniors, including telehealth trials for patients living with congestive heart failure, a randomized trial in anemia of chronic disease and a study to predict site of death in end of life patients.
Dr. Potters conducts research in prostate cancer, with a focus on prostate brachytherapy techniques and outcomes. He also works on systems and process research for high-quality and safe treatment of innovative care and delivery models.
VALENTIN A. PAVLOV, PHDBiomedical Science
RENEE PEKMEZARIS, PHD Patient-Oriented Research
LOUIS POTTERS, MD Oncology & Cell Biology
29
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
RESEARCH DIRECTORY
Dr. Rothsteins lab aims to clarify the role and function of B lymphocytes in health and disease. His focus is on human B1 cells, a unique B lymphocyte subset that produces natural antibody and regulates T-cell activity. Human B1 cells may be important in understanding and treating autoimmune diseases and degenerative diseases of aging.
Dr. Rai collaborates in basic and clinical research to conduct a number of experimental drug trials for patients suffering from chronic lymphocytic leukemia (CLL), a cancer that resides in the blood, bone marrow and lymphoid tissues. His studies have impacted CLL patient prognosis and care.
Dr. Ruggieri researches glioblastoma and medulloblastoma, the most common types of brain tumors in adults and children. She is working on the development of an inhibitor that could provide novel treatments for these types of tumors.
Dr. Rilos expertise are conducting clinical islet cell transplant for patients suffering from chronic pancreatitis and type 1 diabetes, and performing immunotherapy for pancreatic cancer. His research focuses on mitigating transplant rejection, preservation of donor organs and development of stem cell therapies to treat life-threatening diseases.
Dr. Santiago-Schwarzs research is concerned with the control of monocyte and dendritic cell development in normal and abnormal physiology as well as developing new therapeutic agents for autoimmune diseases. Current work focuses on disrupted cytokine and immunoreceptor networks affecting monocyte/dendritic cell activity, particularly in rheumatoid arthritis and lupus.
Dr. Robinson and his first-episode schizophrenia research network, which includes sites across the country and in Canada, study pharmacotherapy for schizophrenia. The network is currently conducting the RAISE trial, which assesses psychosocial and pharmacological treatments for schizophrenia.
Dr. Powell is involved in cardiac metabolism research and examines the role of the ubiquitin proteasome system in cellular function and malfunction. He conducts ongoing studies that examine altered function of the ubiquitin proteasome system in several diseases.
Dr. Roths research is focused on obesity and diabetes. Projects include devising earlier ways to diagnose and treat diabetes, understanding how excess body weight brings out diabetes, and uncovering how the microbiome, the microbes in the intestine of the host, influence the hosts food intake and body weight.
THOMAS L. ROTHSTEIN, MD, PHD Oncology & Cell Biology
KANTI R. RAI, MD Chronic Lymphocytic Leukemia
ROSAMARIA RUGGIERI, PHD Oncology & Cell Biology
HORACIO RILO, MD Translational Research
FRANCES SANTIAGO-SCHWARZ, PHDAutoimmune &
Musculoskeletal Disease
DELBERT G. ROBINSON, MDPsychiatric Neuroscience
SAUL R. POWELL, PHD Heart & Lung Research
JESSE ROTH, MDBiomedical Science
30
2015 ANNUAL REPORT
-
RESEARCH DIRECTORY
Dr. Schleien researches cardiopulmonary resuscitation, including brain-blood flow, drug effects, metabolism and mechanics of CPR. Recently, his focus has been in pediatric CPR and hypothermia following cardiac arrest in children. He also has an interest in clinical bioethics in children, as well as other critical care topics.
Dr. Schulder investigates new methods of image guidance for neurosurgery, including the incorporation of functional MRI as well as intraoperative MRI.
Dr. Shafritzs research examines the neural and cognitive mechanisms of attention, executive function and emotion. He also studies psychological disorders that involve dysregulation of these processes, such as autism and attention deficit hyperactivity disorder. He works to determine the brain mechanisms underlying behavioral disorders so that future treatments can target those specific brain areas.
Dr. Schanler researches neonatal nutrition and critical inflammatory disorders of newborns. His nutritional and anti-inflammatory studies aim to provide better outcomes for infants in the neonatal intensive care unit.
Dr. Sherrys research interest is in the mechanisms that coordinate the innate immune response. Her ultimate goal is to gain a better understanding of the molecular mechanisms that regulate chemokine and chemokine receptor responses in healthy individuals, and to identify how these pathways are dysregulated in sepsis, HIV infection and chronic lymphocytic leukemia.
CHARLES SCHLEIEN, MD Patient-Oriented Research
MICHAEL SCHULDER, MDNeuroscience
KEITH M. SHAFRITZ, PHDPsychiatric Neuroscience
RICHARD J. SCHANLER, MD Immunology & Inflammation
BARBARA SHERRY, PHD Immunology & Inflammation
Dr. Silverman researches pre-diabetes and diabetes in emergency room patients, as well as the effects of air pollution on asthma-related hospital admissions. He also studies air pollution and cardiac deaths that occur outside of the hospital.
Dr. Simpkins uses si/sh RNA knockdown techniques to study the molecular mechanisms of cisplatin resistance that develops in tumor cells. He is studying his area of medicine to create safer, more effective chemotherapies.
Dr. Singh is focused on elucidating the pathways responsible for the cancer predisposition in patients with bone marrow failure syndromes. A recent research focus is on determining the impact of ribosomal protein haploin sufficiency on the immune system.
ROBERT A. SILVERMAN, MDPatient-Oriented Research
HENRY SIMPKINS, MD, PHDPatient-Oriented Research
SHARON SINGH, MD Oncology & Cell Biology
31
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
RESEARCH DIRECTORY
Dr. Symons has focused his research on the molecular dissection of signaling pathways that are responsible for tumor cell invasion and survival, with current emphasis on brain tumors. The research focuses on two types of malignant tumors: glioblastoma and medulloblastoma.
Dr. Soffer studies mechanisms of metastasis and resistance to anti-angiogenic therapies in pediatric soft tissue sarcomas. The goal is to prevent micro-metastatic disease following tumor resection in a host of pediatric solid tumors.
Dr. Szeszko uses MRI to study the brains of patients who suffer from psychiatric disorders in order to identify structural and functional abnormalities that play a role in the pathogenesis of disorders including schizophrenia, bipolar disorder and obsessive-compulsive disorder. He also identifies neuroimaging predictors of treatment response and outcome.
The research focus of Dr. Son is on a pathogenic pathway in lupus; specifically the fundamental tolerance role of complement C1q in immune system. She studies the function of LAIR-1 and manipulating C1q and LAIR-1 for down-regulation of myeloid cells to improve the severity of lupus.
Dr. Talwar studies translational research in pulmonary medicine with a focus on pulmonary hypertension and advanced lung disease. He also researches comorbidities of these diseases and their impact on patients mental health and quality of life.
Dr. Singhals research is focused on studying the mechanism of the progression of renal lesions in patients with HIV-associated nephropathy (HIVAN), a complication of AIDS. He also studies the effects of opiates and ethanol on T cell injury.
Dr. Traceys research focus is inflammation, the physiological and immunological response to infection and injury and the mechanism by which neurons control the immune system. Most recently, he has made discoveries in bioelectronic medicine. Bioelectronic medicine tells nerves to produce the natural chemicals the body uses to cure itself.
Dr. Steinbergs research is primarily focused on diseases of the airway caused by human papillomaviruses (HPVs). One of these diseases is recurrent respiratory papillomatosis (RRP). She also studies HPV-induced head and neck cancers.
MARC H. SYMONS, PHD Oncology & Cell Biology
SAMUEL Z. SOFFER, MD Oncology & Cell Biology
PHILIP R. SZESZKO, PHD Psychiatric Neuroscience
MYOUNGSUN SON, PHD Autoimmune &
Musculoskeletal Disease
ARUNABH TALWAR, MDHeart & Lung Research
PRAVIN C. SINGHAL, MD Immunology & Inflammation
KEVIN J. TRACEY, MD Biomedical Science
BETTIE M. STEINBERG, PHDOncology & Cell Biology
32
2015 ANNUAL REPORT
-
RESEARCH DIRECTORY
Dr. Ulug is experienced in functional applications of MRI, such as functional MRI (fMRI) and MR spectroscopic imaging (MRSI). His research focuses on neuroimaging applications of MR diffusion tensor imaging (DTI).
Dr. Vaiselbuh specializes in histiocytic disorders, pediatric leukemia and lymphoma and her research focuses on stem cell niche biology and the tumor microenvironment.
Dr. Vambutass research interests are in the restoration of natural hearing in patients with immune-mediated hearing loss who are resistant to conventional corticosteroid therapy. She is currently studying how to prevent further hearing loss and identify new biologic markers in these patients.
Dr. Vlachoss research focuses on inherited bone marrow failure syndromes, particularly Diamond Blackfan anemia (DBA). Her goal is to better understand the epidemiology and biology of this red cell disorder, and ultimately discover better diagnostic and treatment options.
AZIZ M. ULUG, PHD Neuroscience
SARAH VAISELBUH, MDOncology & Cell Biology
ANDREA VAMBUTAS, MDAutoimmune &
Musculoskeletal Disease
ADRIANNA VLACHOS, MD Patient-Oriented Research
Dr. Volpe studies recovery after neurological injury with non-invasive technology including interactive robot training and transcranial direct current stimulation (tDCS). His group is also exploring the effect of repetitive trans-cranial magnetic stimulation (rTMS) on brain metabolism using PET technology.
The intent of Dr. Wangs research is to uncover the mechanisms underlying the pathogenesis of inflammatory diseases, including cerebral ischemic injury and sepsis. He is working to identify novel therapeutic targets to fight against severe injury- and infection-elicited dysregulated inflammation.
Dr. Wangs research goal is to develop better therapies to prevent septic onset and progression. He and his team members are studying several potential drug candidates for the treatment of sepsis and other organ injuries including hemorrhagic shock, acute kidney injury, ischemia-reperfusion injury, stroke and radiation injury.
Dr. Yang studies the immune system and diseases caused by inflammation, with a focus on sepsis. Specifically, she studies the molecular basis of sepsis in order to develop an improved treatment for sepsis.
BRUCE T. VOLPE, MDBiomedical Science
HAICHAO WANG, PHD Biomedical Science
PING WANG, MD Translational Research
HUAN YANG, MD, PHD Biomedical Science
33
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
RESEARCH DIRECTORY
Dr. Zhangs research goal is to improve treatment outcomes of patients with schizophrenia and other psychiatric disorders. Current research is focused on pharmacogenomics of antipsychotic drug response, using genomic markers to predict medication efficacy and side effects. He treats and studies patients with early stages of schizophrenia.
Dr. Zou studies hematopoietic stem cell (HSC) function under normal and inflammatory conditions. Another current focus is on how inflammatory factors affect the bone morrow microenvironment and differentiation of stromal cells in lymphoid organs in autoimmune diseases.
JIANPING ZHANG, MD, PHD Psychiatric Neuroscience
YONG-RUI ZOU, PHD Autoimmune &
Musculoskeletal Disease
34
2015 ANNUAL REPORT
-
Robert B. CatellAnthony Cerami, PhDNicholas Chiorazzi, MDSusan B. ClasterSteven M. CohenThomas J. Degnan, MDMichael A. EpsteinLeonard FeinsteinLloyd M. GoldmanSusan KarchesCurt N. LaunerMarjorie Boas Levins
Seth LipsayNancy A. MarksCharles MerinoffSusan L. MerinoffEdward D. MillerRalph A. NappiPeter J. Pappas, JrLewis S. RanieriJack J. RossMichael C. SladeKevin J. Tracey, MDBarbara Hrbek Zucker
Mark L. ClasterMichael J. DowlingLaurence A. KraemerLaura S. Peabody
Robert S. ShapiroBettie M. Steinberg, PhDAndrew C. Yacht, MD
BOARD OF DIRECTORS
EX-OFFICIOS
35
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
Philanthropy and Health System Support
$45,583,188
Grants Revenue$44,445,382
Licensing, Royalties and Other
$2,342,043
Total Research Investment
$73,848,962
Facilities and Capital Spending
$9,246,960
Total Administrative Cost
$9,634,144
FINANCIAL SUMMARY FOR THE YEAR ENDED DECEMBER 31, 2014 (UNAUDITED DOLLARS)
Total Revenue $92,370,613
Total Expense $92,730,066
36
2015 ANNUAL REPORT
-
DONORS
57 Bay Street Associates
Lorraine S. Aaron u
Aaronson Rappaport Feinstein & Deutsch, LLP u
Mr. Arthur A. Abeles
Abilene, Inc.
Mr. Herbert Aboff
Mr. and Mrs. Michael Aboff u
Aboffs Inc.
Mr. and Mrs. Richard S. Abramson l
Louis & Anne Abrons Foundation Inc.
Mr. and Mrs. William Achenbaum l
Mr. and Mrs. Richard H. Ader
Mr. Paul R. Ades u
The Adikes Family Foundation u
Advantage Title Agency, Inc.
AdvantageCare Physicians
Aeroterm US Inc. AAF
AFCO Insurance Premium Finance
Affinion Group
Aflac
Ms. Galina Agapov
Mr. Herbert S. Agin and Dr. Denny Agin
Mr. Greg A. Agran u
Ainslie Foundation
Air Serv Corporation
Airline Vending Services, Inc.
Airway Maintenance, LLC
The Alan T. Brown Foundation to Cure Paralysis
Mona Fishman Albert and Andrew Albert s
Mr. and Mrs. Wayne Albinder
Alcon Laboratories, Inc.
Mr. and Mrs. Michael W. Alderman
Mr. and Mrs. Michael J. Alesandro u
Mr. and Mrs. John W. Alexander u
Allergan, Inc.
AllianceBernstein
Alliance for Lupus Research s
Alliance Ground International, LLC
Allied Aviation Services, Inc
Alonna, LLC
Ms. Adelah AlSayer
Mr. and Mrs. Charles M. Alter
Mr. and Mrs. Philip S. Altheim u
Altman Warwick, Inc.
American Academy of Dermatology
American Academy of Family Physicians Foundation
American Heart Association u
American Land Services, Inc.
American Orthopaedic Society for Sports Medicine
American Regent, Inc.
American Signcrafters
The American Society of Hematology u
Mr. and Mrs. Peter Amoruso
Amster, Rothstein & Ebenstein LLP
Mr. and Mrs. Albert Anastasi
Mr. and Mrs. Arthur A. Anderman s
Ms. Christine Anderson-Vietri
Angels on the Bay, Inc. u
The Anikstein Family u
Annidis Health Systems Corporation
Anonymous l
Anonymous s
Anonymous u
Anonymous
Mr. Charles Apelian
Mr. and Mrs. Nishan Apelian l
Apollo Security, Inc.
Appliance World of Huntington
Dr. Brahim Ardolic
Arizona Beverages USA
Arnone, Lowth, Wilson, Leibowitz, Andriano & Greco, Inc.
Mr. and Mrs. Carlos A. Arredondo
Ms. Elena I. Arredondo
Ms. Marisa Arredondo
Mr. William Artemenko
Arthritis Foundation
Mr. and Mrs. Russell M. Artzt s
ASCAP u
Mr. and Mrs. George Asch u
Ms. Margaret M. Ash
Mr. and Mrs. Michael L. Ashner l
Assets Recovery Center, LLC
Dr. and Mrs. Mark E. Astiz
Astoria Bank s
Atria Senior Living u
Au Bon Pain
AXA Advisors
Mr. and Mrs. Stuart F. Ayre
Mr. and Mrs. Henry D. Babcock, Jr.
BAE Systems
N. Bailey & H. Kirshner Foundation
Mr. and Mrs. Morgan Bale
Ms. Audrey R. Balog
Mr. and Mrs. Thomas M. Bancroft u
Norwood Foundation, Inc.
Mr. and Mrs. Douglas Band
Banfi Vintners Foundation s
Bank of America, N.A. s
Jeanine and Merrill Banks u
Lloyd Staffing
BankUnited
Ms. Joanne Barbara u
2014 Honor RollThe North Shore-LIJ Health System is grateful for the continued support of so many friends. We wish to thank all of our donors whose generosity and ongoing partnership enable us to fulfill our mission of improving the health of the communities we serve.We make every effort to be accurate and complete in this donor listing. If you have any questions with regard to how your name and/or organization appears, please contact the North Shore-LIJ Health System Foundation at 516-465-2550.The names listed below represent donors, corporations and foundations that have made cumulative gifts of $2,500 or more in 2014. Symbols appearing next to listings reflect lifetime giving.
H $10,000,000+ n $5,000,000 l $1,000,000 s $500,000 u $100,000
37
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
Barbash Family Fund, Inc. l
Ms. Cathy Barbash l
Mrs. Lillian Barbash l
Mr. Shep Barbash l
Ms. Susan Barbash l
Harbour Club, LLC
Mr. and Mrs. Christopher J. Barber u
Mr. and Mrs. Anthony F. Barbiero
Barclays Capital
Judy and Ron Baron
Mr. and Mrs. Manuel H. Barron
Mr. and Mrs. Stanley F. Barshay u
Bartlett, McDonough, Bastone & Monaghan, LLP u
Mr. and Mrs. Ralph M. Baruch l
Mrs. Sandra Atlas Bass H
Mr. David W. Baum u
The Incorporated Village of Bayville
Mr. Kevin S. Beiner
Dr. Alessandro G. Bellucci
Mr. and Mrs. Paul Berger
The Sol and Margaret Berger Foundation l
Mr. James Bergstrom
The Berlin Family Foundation u
Mr. and Mrs. Sidney Berman
Mr. Martin W. Bernard u
Mr. Abraham Bernstein
Jill and Jay Bernstein Family Foundation u
Mr. and Mrs. Frank J. Besignano
Bessemer Trust
Bestcare, Inc.
Bethpage Federal Credit Union
David J. Beyda Memorial Foundation
Ms. Jennifer L. Bickhardt
Biener Auto Group Inc.
Carl Vincent Bini Memorial Fund
Biomedical Research Models, Inc.
Bio-Reference Laboratories u
Mr. and Mrs. O. F. Biondi Jr.
Biotronik, Inc
Dr. Fabien D. Bitan
Mr. and Mrs. Leon Black u
Ms. Elise M. Bloom and Mr. Gregory I. Rasin
Bloomingdales u
Mr. Eric S. Blumencranz s
BWD Group, LLC
Mr. and Mrs. Roger A. Blumencranz l
BWD Group, LLC
Mr. and Mrs. Edward Blumenfeld and Family l
Mr. Charles Blumenkehl
Mr. and Mrs. J. Robert Blumenthal
BNP Associates, Inc
Mr. and Mrs. Andrew Boas l
Dr. and Mrs. Richard S. Boas l
Mr. and Mrs. John Bohlsen n
Bohlsen Restaurant Group
Mr. and Mrs. Geoffrey T. Boisi s
Dr. and Mrs. Richard J. Bonanno
Mr. and Mrs. Joseph Bongiorno
ADJO Contracting Corporation
Mr. and Mrs. Anthony Bonomo l
Physicians Reciprocal Insurers
Dr. John A. Boockvar
Boston Scientific Corporation u
Botto Mechanical Corporation
Mr. William Bowles
Mr. Kevin Boyle
BP Elevator Co.
Brain and Behavior Research Foundation l
The Brain Aneurysm Foundation u
Dr. Lenore Brancato and Dr. Louis Potters
Norbert & Henry Bratt Charitable Trust
Mr. E. Steve Braun H
Mr. and Mrs. Harry P. Braunstein
Dr. Richard Braunstein
Brean Capital, LLC
Mr. Fred Brettschneider
Laura Louise Breyer
Bridgehampton National Bank
Bridgehampton Stone, Inc.
Bridgewater Associates, LP
Dr. Derek Brinster
Brock Solutions
Mr. and Mrs. Bert E. Brodsky u
Mr. and Mrs. Chester F. Broman
Mr. and Mrs. Robert Brooks
Mr. and Mrs. Dayton T. Brown, Jr. l
The William Brown Foundation, Inc. u
Mr. Daniel H. Broxmeyer
Mr. Evan Broxmeyer
Estate of Mark Broxmeyer l
Mr. and Mrs. Michael Broxmeyer
Ms. Rebecca Broxmeyer
Mrs. Tracy L. Broxmeyer l
Dr. Michael S. Bruno l
Estate of Emelda E. Burns u
Busch White Norton, LLP
Mr. and Mrs. Allen E. Busching u
Drs. Annabella Bushra and Peter Abrons
Dr. Richard T. Byrnes
CA Technologies H
Cablevision
Mr. Joseph R. Cabral
Dr. Jean Cacciabaudo and Dr. William Maiorino
Mr. Joseph G. Cairo, Jr.
The Pat Cairo Family Foundation Inc. u
Mr. and Mrs. Salvatore Calcagno
Mr. James W. Callanan
Cameo Import Inc.
Cameron Engineering & Associates, LLP
Mr. and Mrs. William J. Candee, III
Ann and Peter Cannell u
Jonathan S. Canno and Pierce Roberts Canno s
Capell, Barnett, Matalon & Schoenfeld, LLP
Mr. Salvatore Capitano
Ms. Lucinda M. Cardinal and Mr. Daniel S. Tamkin u
Mr. and Mrs. Michael G. Caridi u
Carillon Nursing & Rehabilitation Center
Mr. and Mrs. Robert A. Carlstrom u
Dr. Maria T. Carney and Mr. Joseph M. Carney
Bonnie Cashin Fund
Dr. Miriam Caslow and Mr. Robert J. Caslow
Mr. and Mrs. Frank Castagna l
Fifth Avenue of L.I. Realty Associates
Mr. and Mrs. Robert F. Castano
Mr. Peter Castle
Mr. Frederick Catanese
Mr. and Mrs. Robert B. Catell s
Ms. Colleen Cavaliere
Centennial Elevator Industries, Inc.
Central General Medical & Dental Staff u
Century 21 Associates Foundation Inc. u
Century Elevator Maintenance Corporation
The Anthony Cerami and Ann Dunne Foundation for World Health l
Certilman Balin Adler & Hyman, LLP u
Clifford Chance US, LLP
Dr. Kenneth B. Chapman
Charles H. Thorne, M.D., PLLC
The Chasanoff Foundation, Inc. l
Mr. and Mrs. Robert W. Chasanoff l
Mr. Stanley Chera
Mr. and Mrs. Edward A. Chernoff l
MARS
Childrens Hospital Foundation
Childrens Medical Fund of New York H
Childrens Miracle Network Hospitals n
Mr. Richard Chipman u
CHIPS Technology Group, LLC
Mr. Andrew Chonoles
Chubb & Son, Inc.
Cigna Health and Life Insurance Company
Cincinnati Childrens Hospital Medical Center
Circulatory Technology, Inc. u
Citigroup
Mr. and Mrs. Jerry Clair u
Ms. Joan Claster and Mr. Leonard Kaye
Mr. and Mrs. Mark L. Claster n
Carl Marks Foundation, Inc.
The Clinton Family Foundation
CLK Commercial Management
CLL Global Research Foundation u
Club House Italia of USA LLC
CNA Foundation
Estate of Arthur G. Cohen
Mr. and Mrs. Edward M. Cohen
Hiram Cohen & Son, Inc.
Mr. and Mrs. Jonathan Cohen
Mr. and Mrs. Michael S. Cohen
Mr. and Mrs. Ronald Cohen
Ms. Sharon J. Cohen l
Mr. and Mrs. Steven A. Cohen H
Mr. and Mrs. Steven M. Cohen and Mrs. Bernice Cohen l
38
2015 ANNUAL REPORT
-
Mr. and Mrs. Maurice J. Cohn l
Max B. Cohn Family Foundation
Mr. Seymour Cohn
Sol Cohn Foundation
Estate of Louise Colavito
Cold Spring Hills Center for Nursing & Rehabilitation
Ms. Karen Coleman
Mr. and Mrs. John K. Colgate, Jr. s
Simon & Eve Colin Foundation, Inc. u
Colliers International LI Inc.
Compass Group, North America
Computershare Trust Company of Canada
Mr. Michael Condran
Mr. Dennis Connors
Mr. Thomas Constance
Mr. Michael P. Contillo
Mr. and Mrs. Robert F. Castano
Mrs. Alison Conyngham Neisloss
Conyngham Foundation Agency
Frederic W. Cook & Co., Inc.
Mr. Jonathan D. Cooper
Spectronics Corporation
Mr. and Mrs. John Corrado
The Corso Family Foundation - Care of Joseph Corso
Mr. and Mrs. Konstantine Costalas
Dr. and Mrs. Peter D. Costantino
Costco Wholesale l
Ms. Eileen V. Costello
The Craigmyle Foundation s
Cravath, Swaine & Moore LLP
Dr. and Mrs. James M. Crawford
Credit Union Miracle Day, Inc.
Mr. and Mrs. Peter O. Crisp n
Mr. and Mrs. Brad Cronin
Ellen and Daniel Crown l
Dr. Eric S. Cruzen
Ms. Josephine Cupo
Michele and James Cusack
Drs. Patricia and Fred Cushner
Cystic Fibrosis Foundation u
D & D Elevator Maintenance, Inc.
Drs. Catherine A. DAgostino-Barakat and Richard R. Barakat
Dr. John DAngelo
Mr. and Mrs. Joseph F. DAngelo u
DAL Global Services, LLC
Jillian E. Daly Foundation u
Damaghi Families l
Farahnaz and Babak Damaghi
Haleh and Kambiz Damaghi
Mitra and Nader Damaghi
Shahnaz and Nasser Damaghi
Morris & Rose Danzig Charitable Trust u
Mr. and Mrs. Philippe P. Dauman u
David Lerner Associates u
Mr. Robert G. Davidoff
Estate of Irwin Davis l
Ms. Katherine M. Davis
Mr. and Mrs. Lawrence S. Davis l
Davis Vision
Ms. Alyssa Davner
Mr. and Mrs. Francois X. de Mallmann
The De Rosa Foundation for Colon Cancer Research and Prevention u
Mrs. Vincent de Roulet l
Ira W. DeCamp Foundation u
DeCorato Cohen Sheehan & Federico u
Degmor, Inc.
DEI Incorporated
Peter & Jeri Dejana Family Foundation u
Mr. and Mrs. Claudio Del Vecchio
Deloitte & Touche LLP
Delta Air Lines u
Dr. and Mrs. Louis DeLuca
Mr. and Mrs. Manfred E. Demenus
Dentons
Department of Pediatrics, SIUH
Mr. and Mrs. Thomas E. Dewey, Jr. s
Dr. Kush Dholakia
Diamond Blackfan Anemia Foundation
The DiBenedetto Family Foundation
DiFazio Power & Electric, LLC
Mr. and Mrs. Jack DiMaio
Mr. Joseph DiMartino u
Dime Savings Bank of Williamsburgh
Dr. Michael Y. Divon u
Donaldson Interiors, Inc.
Mr. and Mrs. Thomas E. Dooley l
Mr. and Mrs. Lawrence Doppelt u
Barbara Dorsch Foundation
Mr. and Mrs. John C. Doscas
Douglas Elliman Real Estate u
Mr. and Mrs. Michael J. Dowling
Robert N. and Nancy A. Downey l
Mr. Damien Drab
Mr. and Mrs. Daniel J. Driscoll
Mr. and Mrs. Michael J. Driscoll
Mrs. Ruth A. Drucker u
Duenas Trucking
Duffner & Voigt Inc.
The Norma Duncan Testamentary Trust
Dunkin Donuts/Baskin Robbins Foundation
Mr. Thomas Durkin
E.I.B. LMCC Fund
Eagle Capital Management, LLC
Henry M. Ebbitt Trust
Paul R. Eckna Memorial Foundation
Dr. David R. Edelstein and Ms. Eve Lesser
Edgewood Management, LLC
The Eger Foundation
Mr. and Mrs. David Einbinder u
Dr. and Mrs. Mark B. Eisenberg
Mr. and Mrs. Martin Eisenberg
Mr. and Mrs. Ronald Eisenberg
Mr. and Mrs. Saul Eisenberg u
The Charles L. Read Foundation
Mr. and Mrs. Warren Eisenberg u
Eisenhardt Mills, Inc.
Mr. and Mrs. Adam Elberg
Mr. Christopher Eler
Mr. Martin Elias l
Ike, Molly & Steven Elias Foundation
Ms. Theresa Elkowitz
Dr. Marty Ellington
Thomas and Jeanne Elmezzi Private Foundation H
Emergency Medicine Services of SI, PC u
Empire Office Equipment
Endometriosis Foundation of America, Inc. u
Mr. and Mrs. Peter Engel
Mr. and Mrs. Daniel Englander u
Mr. and Mrs. Israel Englander l
Mr. Charles Entenmann u
Mr. Robert Entenmann
Family of William Entenmann
Entertainment Industry Foundation
Epilepsy Foundation
Epilepsy Study Consortium, Inc.
Mr. Michael Epstein and Ms. Lisa Martin Epstein l
Dr. and Mrs. Neal F. Epstein
Mrs. Phyllis Epstein
Mr. and Mrs. Scott Erlich
Essig Electrical Services, Inc.
The Estee Lauder Companies Inc. s
Etchepare Family Foundation
Mr. and Mrs. Bernard Ettinger u
Evercore Trust Company
Extended Nursing Personnel, CHHA u
ExxonMobil Foundation
Eye Care Centers of America, Inc.
EZE Software Group
F.A.C.T. Long Island Foundation
Fache Industries, Inc.
Faegre Baker Daniels, LLP
Mr. and Mrs. Peter M. Fahey u
Fan Fox and Leslie R. Samuels Foundation, Inc. l
Farrell Fritz, P.C.
Ms. Cara Faske
FBR Capital Markets & Company
Foundation of the American College of Allergy, Asthma & Immunology
Mr. and Mrs. Robert Feidelson
The Louis and Gertrude Feil Family H
Mr. David H. Feinberg
Mr. and Mrs. Frank Feinberg H
Mr. and Mrs. Herbert Feinberg u
Drs. Sheryl and Randall Feingold
Ms. Amy Feinstein u
Mr. and Mrs. Jeffrey L. Feinstein u
Mr. and Mrs. Leonard Feinstein H
Mr. and Mrs. Richard S. Feinstein u
Mr. and Mrs. Michael E. Feldman u
Ms. Ann Feldstein
Mr. and Mrs. Marshall Felenstein u
Mrs. Amy Feller
Mr. and Mrs. Larry Fenster
Mr. and Mrs. Anthony C. Ferreri u
Mr. and Mrs. Christopher C. Ferreri
Mr. and Mrs. Joseph Ferreri
Mr. and Mrs. Fredric Fetkowitz
Ficalora Family Foundation u
H $10,000,000+ n $5,000,000 l $1,000,000 s $500,000 u $100,000
39
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
Dr. and Mrs. David H. Fields u
Dr. and Mrs. Noah S. Finkel
Mr. and Mrs. David S. Finkelstein
Joel Finkelstein Cancer Foundation H
Mr. and Mrs. Brian Finn u
First Presbyterian Church The Clothes Line
Fiserv Solutions, Inc.
Mr. and Mrs. Daniel Fisher u
Mr. and Mrs. Robert Fisher
Dr. Nick Fitterman
Five Corners Car Wash
Flightstar Aircraft Services, LLC
Florence Corporation
Mr. and Mrs. Thomas J. Flynn u
The Ford Foundation
The Morris and Natalie Forgash Foundation
Mr. Alan Forman
Altronix Corporation
Dr. Victor Fornari
Dr. Jamie A. Fortunoff and Dr. Paul P. Romanello
Mr. and Mrs. Robert Fortunoff u
The Foundation for READ
Foundation for Surgical Fellowships u
The Foundation of the AAGL
Michael J. Fox Foundation for Parkinsons Research s
FragranceNet.com
Frank Crystal & Company
The Frank Family Foundation
Abraham B. & Sarah Frank Fund u
Dr. and Mrs. Douglas K. Frank
Franklin Hospital - Medical Staff Fund s
Mr. and Mrs. William H. Frazier u
Fresh Meadow Country Club s
Mrs. Carolyn W. Fried
Dr. Ethan Fried and Mrs. Joan Bester
The Fried Foundation, Inc. u
Fried, Frank, Harris, Shriver & Jacobson, LLP
The Raphael D. and Francine Friedlander Foundation l
Friedman Benda, LLC
Mr. Clifford H. Friedman u
The Gerald J. and Dorothy R. Friedman New York Foundation n
Ms. Ruth Friedman
Friends and Angels: The Tracy Vicere Foundation, Inc.
Friends of Maya Chang, Inc.
Mr. Scott Frishman u
Philip J. Hahn Foundation
Mr. Glen Froio
Mr. and Mrs. Tony Fromer
Mr. and Mrs. Robert L. Fromer l
Mr. Alan J. Fumuso
Fumuso, Kelly, DeVerna, Snyder, Swart & Farrell, LLP
Estate of Agnes Trill Funk u
The G & A Foundation u
Mr. and Mrs. Henry Gabbay u
Mr. and Mrs. Gregory G. Galdi
Custom Computer Specialists
Mr. Stanley C. Gale s
The Gambino Medical & Science Foundation, Inc. n
Mr. and Mrs. Thomas Gambino, Sr.
Mr. and Mrs. Leif Arntzen
Mr. and Mrs. Carl Gambino
Mr. and Mrs. Thomas Gambino, Jr.
Mr. and Mrs. Andrew Rotondi
Howard L. and Judie Ganek Philanthropic Fund
Garden City Rams - Boys Lacrosse, Inc.
Estate of Robert B. Gardner, Jr. l
Garfunkel Wild, P.C. u
Dr. Kirk N. Garratt
George A. Gaston Charitable Trust u
Gates Capital Corporation
Mr. Eric Gatoff
Nathans Famous Services, Inc.
Gavins Got Heart
Mr. Michael J. Geiger
Genentech, Inc. u
Mr. and Mrs. Robert Genser
Ms. Gladys George and Dr. Stuart Orsher s
Mr. and Mrs. Raymond L. George, III
Mr. and Mrs. Gary M. Geresi
Myrna and Freddie Gershon
The Gershwind Family Foundation l
Mr. and Mrs. J. R. Getz
Mrs. Ronnie Pashcow Getz
GGG Construction Corporation
Ms. Rene A. Giacalone u
Mr. and Mrs. Anthony T. Giaccone u
Intermarket Insurance Agency Inc.
Mr. and Mrs. Christopher C. Giamo
Mr. John V. Gibson u
Mr. and Mrs. Alan R. Gilbert
Mr. S. Parker Gilbert u
Gilead Sciences, Inc.
Mr. and Mrs. Edward M. Giles
The Clark Gillies Foundation l
Aaron & Betty Gilman Family Foundation
Mr. Abraham Gindi u
Mr. and Mrs. Myron Ginsberg
Giorgio Armani Emporio Armani
Glen Head Charity Fund, Inc. u
Glen Oaks Club, Inc. u
Glen Oaks Philanthropic Fund u
Mr. and Mrs. Ralph Glogower
Roy Henry Glover Memorial Trust s
Mrs. Pearl Glowatz
GM Advisory Group
Mr. and Mrs. Robert Goebert
The Arnold P. Gold Foundation
Mr. Marc Gold
Mr. and Mrs. Alan Goldberg u
Mr. and Mrs. Arthur H. Goldberg u
Edward & Marjorie Goldberger Foundation
Mr. and Mrs. Richard Goldberg
Mr. Robert M. Goldberg n
The Fay J. Lindner Foundation
Dr. and Mrs. Bruce Golden
Mrs. Mildred Golden u
Ms. Edna S. Goldman u
Mr. Jay Goldman l
Mr. and Mrs. Lloyd M. Goldman H
The Joyce and Irving Goldman Family Foundation
Goldman Sachs & Co. l
Elliot Goldofsky, M.D., P.C.
Mrs. Lola Goldring
Mr. and Mrs. Richard D. Goldstein l
Sarah C. Goldstein Irrevocable Trust u
Mr. and Mrs. Robert L. Golub
Mr. and Mrs. Ernest P. Gonzalez
Goodhart National Gorman Agency, Inc.
Dr. and Mrs. Merrill Goodman s
Goody Two Shoes & The Schnittman Family
Mr. and Mrs. Donald J. Gordon u
Gordon & Silber, P.C.
Gordon L. Seaman, Inc. u
Mr. Lawrence Gottesman s
Lawrence Scott Events, Ltd.
Mr. and Mrs. Ronald A. Gottlieb u
Mr. and Mrs. George E. Gottridge s
Dr. Joanne Gottridge-Patrizi and Mr. Lester Patrizi u
Mr. and Mrs. Fredric H. Gould s
The Gould-Shenfeld Family Foundation
Mr. Michael A. Gould s
The Sarah Grace Foundation for Children with Cancer, Inc.
Grandstand Sports & Memorabilia, Inc.
Dr. and Mrs. Albert L. Granger
Granger & Sahasra Endodontic
Granite Building 2 LLC
Mr. Martin Granowitz
Dr. and Mrs. Jeffrey J. Grant u
Great South Bay Y.M.C.A.
Green Art Plumbing Supply
Mr. and Mrs. Martin B. Greenberg s
Mr. and Mrs. Alan I. Greene H
The David and Alan Greene Family Foundation, Inc.
Mr. and Mrs. Richard M. Greene u
The Niki and Joe Gregory Charitable Foundation l
Gristmill Construction Company, LLC
Mr. and Mrs. Leonard S. Gruenberg, Jr.
The Vincent Gruppuso Foundation u
Ms. Joanne Grzelak
Mr. and Mrs. Paul A. Guden
Mr. and Mrs. Lee E. Gunderson
Mr. Francis C. Gunther
Mr. and Mrs. Joseph Gurwin l
Dr. Leo Guthart u
Patricia and Edward Gutman l
The Gynecologic Oncology Group
The H Company, Ltd.
Dr. Robert D. Haar
The Marc Haas Foundation u
Mr. and Mrs. Adam Haber
Ms. Trudi Haberman
40
2015 ANNUAL REPORT
-
Amy Hagedorn n
Mr. and Mrs. Peter R. Haje
Mr. and Mrs. Stephen L. Hammerman s
Hampton Designer Showhouse Foundation, Inc.
Milton and Miriam Handler Foundation s
Hanley Funeral Home, Inc.
Mr. and Mrs. Bernard Hann l
Jeri Finesilver Cancer Foundation
Harboglow, Inc.
Mr. and Mrs. Robert L. Harding s
Harding Educational and Charitable Foundation
Harmonic, Inc.
Ms. Erica Harold
Mrs. Tara Hart and Mr. Edward Tam
Dr. and Mrs. Alan R. Hartman
Mr. and Mrs. Norman H. Harvey u
Mr. Walter H. Haydock
Mr. and Mrs. Stuart M. Hayim u
Mr. and Mrs. Ira Hazan l
Healthcare Association of NYS & Affiliates
Healthfirst, Inc.
Mr. and Mrs. Michael F. Heaney
Friedman, LLP
The William Randolph Hearst Foundations, Inc. l
The Hecht-Levi Foundation
Dr. and Mrs. Lawrence P. Hecker
Heidelberg Engineering
Heidell, Pittoni, Murphy & Bach, LLP
Mr. and Mrs. Steven D. Heinemann
Benjamin J. Heitner, C.P.A., P.C.
Ms. Mary Jane Helenek
Mr. and Mrs. Jonathan N. Helfat u
Mr. Alexander Hellinger
Dr. Jonathan Hemli
Mr. Matthew Henebry
Henry Schein, Inc. s
Elliott and Susan Hershman u
Mr. and Mrs. John B. Hess u
Marlene Hess and James D. Zirin H
Mr. Stephen Hess u
Hewlett Associates, LP
Hightower Holding, LLC
William and Judy Hiltz l
Mr. and Mrs. Randall S. Hinden u
Margaret Mellon Hitchcock Foundation u
Dr. and Mrs. Mark S. Hochberg
Dr. Gary Horbar and Dr. Sharon Hochweiss
Dr. Cynthia and Mr. Robert Hoey
Drs. Ira and Ruth Hoffman u
Mr. and Mrs. Peter J. Hoffman
Mr. and Mrs. Steven R. Hoffman
Helen Hoffritz Charitable Trust s
Hofstra University
Mr. and Mrs. Ronald P. Hohmann
Dr. Peter H. Hollis
Holten Ave., Inc.
The Honeysuckle Foundation for Children with Cancer u
Mr. and Mrs. James B. Hoover u
Dr. Gary Horbar and Dr. Sharon Hochweiss
Mr. and Mrs. Richard A. Horowitz u
Mr. and Mrs. Ron J. Horowitz s
P & F Industries, Inc.
Ms. Catherine Hottendorf
Mr. and Mrs. Randolph G. Howard, Jr.
Mr. and Mrs. David J. Hoyt
HRI Health Research Inc. u
HSBC Philanthropic Programs
Mr. and Mrs. Charles G. Hughes
C. G. Hughes Company
H. M. Hughes Co., Inc.
Hugoton Foundation l
Hunter Douglas
Hunter Roberts Construction Group
Huntington Country Club
Huntington Hills Center for Health & Rehabilitation
Huntington Hospital - Medical Staff s
Huntingtons Disease Society of America u
Mr. and Mrs. Laurence S. Hyman
Mr. and Mrs. M. Allan Hyman u
Ms. Nicole Iacovano
I Chera & Sons Foundation, Inc.
ICOR Associates, LLC
I.J. Peisers Sons, Inc.
Illumina, Inc.
Mr. and Mrs. Richard C. Imbert l
Impact Displays Group
InfoHedge Technologies
Mr. and Mrs. Francis Ingrassia u
Intelli-Tec Security Services
Interboro Management, Inc.
International Asbestos Removal Inc.
International Trade Logistics, Inc.
Investors Bank Foundation
Iranian American Jewish Federation of New York u
Dr. Tochi Iroku-Malize
ISK Institute for Orthopedics and Sports Medicine
Island Medical Specialists, PLLC
Islip Breast Cancer Coalition
ISS Facility Services, Inc.
Mr. Chander S. Iyer u
Mr. Anthony T. Izzo u
Benefits Planning Corporation
Mr. Mark Jacobson l
Mr. and Mrs. Mitchell Jacobson l
MSC Industrial Direct Company, Inc.
Mr. and Mrs. Scott Jaffee
Dr. and Mrs. Mark P. Jarrett
Jaspan Schlesinger, LLP
Estate of Elmer L. Jefferson l
Estate of Helen T. Jefferson u
Mr. and Mrs. James P. Jeffery
JemCap LLC
Jet Way Security & Investigations, LLC
Jewish Community Foundation of Greater Hartford, Inc.
JFK International Air Terminal, LLC
The John W. Engeman Theater at Northport
Jonathan Quattrocchi Sheetrock & Spackling
Mr. and Mrs. Michael D. Jordan u
Mr. Arlin Jorge u
Arlindo & Evelyn Jorge Family Trust u
JPMorgan Chase l
J.S. Held Incorporated
Arnold and Ann Jurdem
Mr. and Mrs. Jeffrey Jurick s
Mrs. Lyn Jurick l
Mr. and Mrs. Harvey B. Kadden
Estate of Marion A. Kahn l
Mr. and Mrs. Edward Kalikow
The Sidney & Pearl Kalikow Foundation
Mr. and Mrs. Jeffrey M. Kanter
Mr. and Mrs. Allen S. Kaplan
Mr. and Mrs. Ramesh Kapoor u
The Karches Foundation H
Mr. and Mrs. Brad Karp
Sotirios Kassapidis, MD, P.C.
Katten Muchin Rosenman Foundation, Inc.
Mr. and Mrs. Alvin Katz
Mr. and Ms. David M. Katz
Ms. Holly Katz
Mr. and Mrs. Michael Katz l
Mr. and Mrs. Robert Katz u
Mr. and Mrs. Saul B. Katz H
Mr. and Mrs. George S. Kaufman
Mr. and Mrs. Ivan Kaufman l
Mr. and Mrs. Marvin A. Kaufman u
Mr. and Mrs. Robert Kaufman n
Mr. and Mrs. Steven Kaufman
Kaufman, Borgeest & Ryan, LLP
Mr. George Kaye
The Kazickas Family Foundation, Inc.
Kck, Inc.
Mr. and Mrs. John C. Kean, III u
Kean Development Company
W.M. Keck Foundation u
The Kelleher Foundation
Kellenberg Memorial High School
Kelley Drye & Warren, LLP u
Mr. and Mrs. Jack Kelly
Mr. Michael Kelly
Mr. and Mrs. Marc Kemp
Mr. and Mrs. J. Donald Kennedy u
Kenneth J. Delaney Contracting Corp.
Dr. James F. Kenny u
Mr. Paul Kesluk
Kidney & Hypertension Specialists of New York, P.C.
Dr. Michael Kim
The David Kimmel Foundation u
Mr. John J. King u
King Kullen Grocery Co., Inc. u
Dr. and Mrs. Alan M. Kisner
Mr. and Mrs. William Kissam
Kiwanis Club of Huntington Childrens Foundation Inc.
Kiwanis, Metropolitan Division
Kiwanis Pediatric Trauma Center, NSUH l
H $10,000,000+ n $5,000,000 l $1,000,000 s $500,000 u $100,000
41
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
-
The Nancy Klauber Forest Foundation u
Dr. Arthur A. Klein
Dr. Victor R. Klein
Dr. Morton Kleiner u
Mr. Mark T. Kleinknecht and Ms. Jessica A. Harter-Kleinknecht
Mr. and Mrs. Richard P. Kleinknecht u
The Kleinknecht Family Foundation
Mrs. Marion Kleinkramer u
KLS Martin, L.P.
B & R Knapp Foundation, Inc. u
Ms. Susan Knoepffler
Mr. and Mrs. David M. Knott u
Kohls Cares l
Ms. Stephanie Kollar
Susan G. Komen Greater New York City u
Dr. Arnold Komisar
Kone, Inc.
Mr. and Mrs. Peter Kossoy
Karen M. Kostroff, MD and Jon R. Cohen, MD u
Mr. and Mrs. Jeffrey T. Kovner u
The Judith C. White Foundation, Inc.
KPMG, LLP u
Mr. and Mrs. Werner H. Kramarsky
Kramer Levin Naftalis & Frankel, LLP
Mr. and Mrs. Jeffrey A. Kraut
Mr. and Mrs. Cary A. Kravet l
Kravet, Inc.
Mr. and Mrs. Scott Kravet
Mr. Stanley Kreitman l
Dr. Yosef P. Krespi
Estate of Florence B. Kressin l
Ms. Francine Kreuter
Mrs. Cathy S. Krieger
Mr. Stuart Kronick
Mrs. Barbara W. Kummel u
The Kupferberg Foundation l
Mr. Max Kupferberg l
Mr. and Mrs. Seth Kupferberg l
Jack & Dorothy Kupferberg Family Foundation
Dr. Marina S. Kurian
Dr. Daniel B. Kuriloff
Dr. Michael Kurzman
The Kurzrok Foundation, Inc.
Mr. and Mrs. Sheldon F. Kwiat u
Dr. and Mrs. Sean Lager
Lakeville Pace Mechanical, Inc.
Mr. and Mrs. Frank Lalezarian u
Mr. and Mrs. Kevin Lalezarian u
Mr. and Mrs. Brian T. Lally
LaMay & Sons, Inc.
Mr. and Mrs. Ralph E. Lambert u
Axis Construction Corporation
Landauer, Inc.
Mr. and Mrs. Jerry Landsberg u
Mr. and Mrs. Clifford P. Lane l
Mr. Hank Lane
Mr. and Mrs. Jeffrey B. Lane l
Mr. Robert Lane
Dr. David Langer
Mr. and Mrs. Alexander M. Laughlin u
Mr. and Mrs. Curtis N. Launer s
The Bernard and Muriel Lauren Foundation
Mr. and Mrs. Mark Lauria u
Mark Lauria Associates, Inc.
Mr. and Mrs. Benjamin Lavon
The Alice Lawrence Foundation, Inc.
Dr. and Mrs. Richard S. Lazzaro
Sol and Mildred Lederman Supporting Foundation u
Dr. and Mrs. David LeDoux
Mr. and Mrs. Gerard G. Leeds l
Mr. and Mrs. Michael S. Leeds l
Mrs. Susan C. Lehrman s
Mrs. Isabel B. Leib
Mr. and Mrs. Jonathan W. Leigh l
Dr. and Mrs. Lyle S. Leipziger u
Lenox Hill Hospital OB/GYN Department
Lenox Hill Medical Anesthesiology, PLLC s
Mr. and Mrs. Leslie A. Lerner
Mr. and Mrs. John Lesser
Mr. and Mrs. Howard M. Lester
The Leukemia & Lymphoma Society, Inc.
Mr. and Mrs. Arthur S. Levine l
Mr. Laurence A. Levine
Dr. Mitchell E. Levine
Mrs. Marjorie Boas Levins and Mr. Jack Levins n
Mrs. Shirley I. Leviton l
Mr. and Mrs. Mark Levitt
Estate of Leo J. Levy u
Mr. and Mrs. Mark D. Levy
Mrs. Valerie Levy u
Mr. and Mrs. Victor P. Levy s
L.I. Automotive Group
Mr. George J. Liebner
Lifetime Brands, Inc.
Mr. and Mrs. Martin Lifton l
Lightpath, Inc.
Mr. and Mrs. Mark S. Lilling u
Limo Almi Foundation l
Mr. and Mrs. Peter J. Linchitz
Mr. and Mrs. Andrew S. Linde